nodes	percent_of_prediction	percent_of_DWPC	metapath
Valproic Acid—HDAC2—Lovastatin—atherosclerosis	0.105	0.141	CbGbCtD
Valproic Acid—UGT2B15—Ezetimibe—atherosclerosis	0.102	0.137	CbGbCtD
Valproic Acid—SLC16A1—Niacin—atherosclerosis	0.0686	0.0928	CbGbCtD
Valproic Acid—SLC16A1—Pravastatin—atherosclerosis	0.0531	0.0718	CbGbCtD
Valproic Acid—UGT1A3—Ezetimibe—atherosclerosis	0.0438	0.0593	CbGbCtD
Valproic Acid—UGT1A3—Simvastatin—atherosclerosis	0.0408	0.0551	CbGbCtD
Valproic Acid—UGT1A3—Lovastatin—atherosclerosis	0.0399	0.054	CbGbCtD
Valproic Acid—UGT2B7—Ezetimibe—atherosclerosis	0.0317	0.0429	CbGbCtD
Valproic Acid—UGT2B7—Simvastatin—atherosclerosis	0.0295	0.0399	CbGbCtD
Valproic Acid—UGT2B7—Lovastatin—atherosclerosis	0.0288	0.039	CbGbCtD
Valproic Acid—SLC22A7—Pravastatin—atherosclerosis	0.0261	0.0353	CbGbCtD
Valproic Acid—SLC22A5—Niacin—atherosclerosis	0.0252	0.0341	CbGbCtD
Valproic Acid—SLC22A8—Pravastatin—atherosclerosis	0.0159	0.0215	CbGbCtD
Valproic Acid—SLC22A6—Pravastatin—atherosclerosis	0.0111	0.015	CbGbCtD
Valproic Acid—CYP2B6—Simvastatin—atherosclerosis	0.00985	0.0133	CbGbCtD
Valproic Acid—CYP3A5—Rosuvastatin—atherosclerosis	0.00835	0.0113	CbGbCtD
Valproic Acid—CYP3A5—Simvastatin—atherosclerosis	0.00776	0.0105	CbGbCtD
Valproic Acid—CYP3A5—Lovastatin—atherosclerosis	0.0076	0.0103	CbGbCtD
Valproic Acid—CYP3A5—Pravastatin—atherosclerosis	0.0076	0.0103	CbGbCtD
Valproic Acid—CYP2C8—Simvastatin—atherosclerosis	0.00746	0.0101	CbGbCtD
Valproic Acid—CYP2C8—Pravastatin—atherosclerosis	0.0073	0.00988	CbGbCtD
Valproic Acid—CYP2C8—Lovastatin—atherosclerosis	0.0073	0.00988	CbGbCtD
Valproic Acid—CYP2C19—Rosuvastatin—atherosclerosis	0.00673	0.00911	CbGbCtD
Valproic Acid—CYP2C19—Simvastatin—atherosclerosis	0.00626	0.00847	CbGbCtD
Valproic Acid—CYP2C19—Lovastatin—atherosclerosis	0.00613	0.00829	CbGbCtD
Valproic Acid—CYP2C9—Rosuvastatin—atherosclerosis	0.0056	0.00757	CbGbCtD
Valproic Acid—CYP2C9—Simvastatin—atherosclerosis	0.00521	0.00704	CbGbCtD
Valproic Acid—CYP2C9—Pravastatin—atherosclerosis	0.00509	0.00689	CbGbCtD
Valproic Acid—CYP2C9—Lovastatin—atherosclerosis	0.00509	0.00689	CbGbCtD
Valproic Acid—CYP3A4—Rosuvastatin—atherosclerosis	0.00326	0.0044	CbGbCtD
Valproic Acid—CYP3A4—Ezetimibe—atherosclerosis	0.00326	0.0044	CbGbCtD
Valproic Acid—CYP3A4—Simvastatin—atherosclerosis	0.00303	0.00409	CbGbCtD
Valproic Acid—CYP3A4—Pravastatin—atherosclerosis	0.00296	0.00401	CbGbCtD
Valproic Acid—CYP3A4—Lovastatin—atherosclerosis	0.00296	0.00401	CbGbCtD
Valproic Acid—OGDH—connective tissue—atherosclerosis	0.00133	0.0533	CbGeAlD
Valproic Acid—OGDH—cardiovascular system—atherosclerosis	0.00116	0.0463	CbGeAlD
Valproic Acid—OGDH—adipose tissue—atherosclerosis	0.00102	0.0409	CbGeAlD
Valproic Acid—HDAC9—cardiovascular system—atherosclerosis	0.00102	0.0409	CbGeAlD
Valproic Acid—UGT1A10—liver—atherosclerosis	0.000973	0.039	CbGeAlD
Valproic Acid—ACADSB—cardiovascular system—atherosclerosis	0.000919	0.0368	CbGeAlD
Valproic Acid—UGT1A6—liver—atherosclerosis	0.000905	0.0363	CbGeAlD
Valproic Acid—HDAC9—adipose tissue—atherosclerosis	0.000899	0.036	CbGeAlD
Valproic Acid—ACADSB—adipose tissue—atherosclerosis	0.00081	0.0325	CbGeAlD
Valproic Acid—HDAC2—Lovastatin—Pravastatin—atherosclerosis	0.000775	0.222	CbGdCrCtD
Valproic Acid—HDAC2—Lovastatin—Simvastatin—atherosclerosis	0.000775	0.222	CbGdCrCtD
Valproic Acid—UGT1A8—liver—atherosclerosis	0.00077	0.0308	CbGeAlD
Valproic Acid—OGDH—liver—atherosclerosis	0.000715	0.0287	CbGeAlD
Valproic Acid—ALDH5A1—adipose tissue—atherosclerosis	0.000713	0.0286	CbGeAlD
Valproic Acid—UGT1A3—liver—atherosclerosis	0.000686	0.0275	CbGeAlD
Valproic Acid—HDAC2—Fluvastatin—Rosuvastatin—atherosclerosis	0.000664	0.191	CbGdCrCtD
Valproic Acid—UGT2B15—liver—atherosclerosis	0.000645	0.0258	CbGeAlD
Valproic Acid—HDAC2—Simvastatin—Pravastatin—atherosclerosis	0.000635	0.182	CbGdCrCtD
Valproic Acid—HDAC2—Simvastatin—Lovastatin—atherosclerosis	0.000635	0.182	CbGdCrCtD
Valproic Acid—ABAT—adipose tissue—atherosclerosis	0.00061	0.0245	CbGeAlD
Valproic Acid—HDAC2—connective tissue—atherosclerosis	0.000599	0.024	CbGeAlD
Valproic Acid—PTGS1—artery—atherosclerosis	0.000598	0.024	CbGeAlD
Valproic Acid—UGT1A4—liver—atherosclerosis	0.000583	0.0234	CbGeAlD
Valproic Acid—ACADSB—liver—atherosclerosis	0.000568	0.0228	CbGeAlD
Valproic Acid—HDAC2—cardiovascular system—atherosclerosis	0.000521	0.0209	CbGeAlD
Valproic Acid—PTGS1—endothelium—atherosclerosis	0.000505	0.0202	CbGeAlD
Valproic Acid—ALDH5A1—liver—atherosclerosis	0.0005	0.02	CbGeAlD
Valproic Acid—UGT1A9—liver—atherosclerosis	0.000489	0.0196	CbGeAlD
Valproic Acid—PTGS1—blood vessel—atherosclerosis	0.000466	0.0187	CbGeAlD
Valproic Acid—SLC16A1—cardiovascular system—atherosclerosis	0.000463	0.0186	CbGeAlD
Valproic Acid—HDAC2—adipose tissue—atherosclerosis	0.00046	0.0184	CbGeAlD
Valproic Acid—ABAT—liver—atherosclerosis	0.000428	0.0171	CbGeAlD
Valproic Acid—CYP2C18—liver—atherosclerosis	0.000427	0.0171	CbGeAlD
Valproic Acid—SLC16A1—adipose tissue—atherosclerosis	0.000409	0.0164	CbGeAlD
Valproic Acid—CYP2A6—adipose tissue—atherosclerosis	0.000403	0.0161	CbGeAlD
Valproic Acid—UGT2B7—liver—atherosclerosis	0.000394	0.0158	CbGeAlD
Valproic Acid—SLC22A7—liver—atherosclerosis	0.000375	0.015	CbGeAlD
Valproic Acid—HDAC2—liver—atherosclerosis	0.000322	0.0129	CbGeAlD
Valproic Acid—SLC16A1—liver—atherosclerosis	0.000287	0.0115	CbGeAlD
Valproic Acid—CYP2A6—liver—atherosclerosis	0.000282	0.0113	CbGeAlD
Valproic Acid—PTGS1—connective tissue—atherosclerosis	0.000239	0.00957	CbGeAlD
Valproic Acid—SLC22A5—adipose tissue—atherosclerosis	0.000233	0.00935	CbGeAlD
Valproic Acid—CYP2B6—cardiovascular system—atherosclerosis	0.00023	0.00921	CbGeAlD
Valproic Acid—CYP2C9—cardiovascular system—atherosclerosis	0.000228	0.00912	CbGeAlD
Valproic Acid—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000217	0.00156	CcSEcCtD
Valproic Acid—Anaemia—Ezetimibe—atherosclerosis	0.000216	0.00156	CcSEcCtD
Valproic Acid—Tinnitus—Pravastatin—atherosclerosis	0.000216	0.00156	CcSEcCtD
Valproic Acid—Malaise—Lovastatin—atherosclerosis	0.000215	0.00155	CcSEcCtD
Valproic Acid—Muscle spasms—Simvastatin—atherosclerosis	0.000215	0.00155	CcSEcCtD
Valproic Acid—Vertigo—Lovastatin—atherosclerosis	0.000214	0.00154	CcSEcCtD
Valproic Acid—Angioedema—Ezetimibe—atherosclerosis	0.000214	0.00154	CcSEcCtD
Valproic Acid—Angiopathy—Niacin—atherosclerosis	0.000214	0.00154	CcSEcCtD
Valproic Acid—Leukopenia—Lovastatin—atherosclerosis	0.000214	0.00154	CcSEcCtD
Valproic Acid—Chills—Niacin—atherosclerosis	0.000211	0.00152	CcSEcCtD
Valproic Acid—Malaise—Ezetimibe—atherosclerosis	0.000211	0.00152	CcSEcCtD
Valproic Acid—Vision blurred—Simvastatin—atherosclerosis	0.00021	0.00152	CcSEcCtD
Valproic Acid—Arrhythmia—Niacin—atherosclerosis	0.00021	0.00152	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000209	0.00151	CcSEcCtD
Valproic Acid—Tremor—Simvastatin—atherosclerosis	0.000209	0.00151	CcSEcCtD
Valproic Acid—Alopecia—Niacin—atherosclerosis	0.000208	0.0015	CcSEcCtD
Valproic Acid—Chills—Pravastatin—atherosclerosis	0.000208	0.0015	CcSEcCtD
Valproic Acid—PTGS1—cardiovascular system—atherosclerosis	0.000208	0.00833	CbGeAlD
Valproic Acid—Insomnia—Rosuvastatin—atherosclerosis	0.000208	0.0015	CcSEcCtD
Valproic Acid—Ill-defined disorder—Simvastatin—atherosclerosis	0.000207	0.00149	CcSEcCtD
Valproic Acid—Arrhythmia—Pravastatin—atherosclerosis	0.000207	0.00149	CcSEcCtD
Valproic Acid—Palpitations—Ezetimibe—atherosclerosis	0.000207	0.00149	CcSEcCtD
Valproic Acid—Paraesthesia—Rosuvastatin—atherosclerosis	0.000206	0.00149	CcSEcCtD
Valproic Acid—Anaemia—Simvastatin—atherosclerosis	0.000206	0.00149	CcSEcCtD
Valproic Acid—Malnutrition—Niacin—atherosclerosis	0.000205	0.00148	CcSEcCtD
Valproic Acid—Alopecia—Pravastatin—atherosclerosis	0.000205	0.00148	CcSEcCtD
Valproic Acid—Cough—Ezetimibe—atherosclerosis	0.000204	0.00147	CcSEcCtD
Valproic Acid—CYP3A5—adipose tissue—atherosclerosis	0.000204	0.00817	CbGeAlD
Valproic Acid—Angioedema—Simvastatin—atherosclerosis	0.000204	0.00147	CcSEcCtD
Valproic Acid—Myalgia—Lovastatin—atherosclerosis	0.000203	0.00146	CcSEcCtD
Valproic Acid—Chest pain—Lovastatin—atherosclerosis	0.000203	0.00146	CcSEcCtD
Valproic Acid—Arthralgia—Lovastatin—atherosclerosis	0.000203	0.00146	CcSEcCtD
Valproic Acid—Anxiety—Lovastatin—atherosclerosis	0.000202	0.00146	CcSEcCtD
Valproic Acid—Dyspepsia—Rosuvastatin—atherosclerosis	0.000202	0.00146	CcSEcCtD
Valproic Acid—Hypertension—Ezetimibe—atherosclerosis	0.000202	0.00146	CcSEcCtD
Valproic Acid—Flatulence—Niacin—atherosclerosis	0.000202	0.00146	CcSEcCtD
Valproic Acid—Malaise—Simvastatin—atherosclerosis	0.000201	0.00145	CcSEcCtD
Valproic Acid—Tension—Niacin—atherosclerosis	0.000201	0.00145	CcSEcCtD
Valproic Acid—Discomfort—Lovastatin—atherosclerosis	0.000201	0.00145	CcSEcCtD
Valproic Acid—Vertigo—Simvastatin—atherosclerosis	0.0002	0.00145	CcSEcCtD
Valproic Acid—Leukopenia—Simvastatin—atherosclerosis	0.0002	0.00144	CcSEcCtD
Valproic Acid—Arthralgia—Ezetimibe—atherosclerosis	0.000199	0.00144	CcSEcCtD
Valproic Acid—Chest pain—Ezetimibe—atherosclerosis	0.000199	0.00144	CcSEcCtD
Valproic Acid—Myalgia—Ezetimibe—atherosclerosis	0.000199	0.00144	CcSEcCtD
Valproic Acid—Nervousness—Niacin—atherosclerosis	0.000199	0.00143	CcSEcCtD
Valproic Acid—Flatulence—Pravastatin—atherosclerosis	0.000199	0.00143	CcSEcCtD
Valproic Acid—Dry mouth—Lovastatin—atherosclerosis	0.000199	0.00143	CcSEcCtD
Valproic Acid—Tension—Pravastatin—atherosclerosis	0.000198	0.00143	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000198	0.00143	CcSEcCtD
Valproic Acid—Dysgeusia—Pravastatin—atherosclerosis	0.000198	0.00142	CcSEcCtD
Valproic Acid—Muscle spasms—Niacin—atherosclerosis	0.000197	0.00142	CcSEcCtD
Valproic Acid—Discomfort—Ezetimibe—atherosclerosis	0.000197	0.00142	CcSEcCtD
Valproic Acid—Pain—Rosuvastatin—atherosclerosis	0.000196	0.00142	CcSEcCtD
Valproic Acid—Constipation—Rosuvastatin—atherosclerosis	0.000196	0.00142	CcSEcCtD
Valproic Acid—Confusional state—Lovastatin—atherosclerosis	0.000196	0.00142	CcSEcCtD
Valproic Acid—Nervousness—Pravastatin—atherosclerosis	0.000196	0.00141	CcSEcCtD
Valproic Acid—Dry mouth—Ezetimibe—atherosclerosis	0.000195	0.0014	CcSEcCtD
Valproic Acid—Anaphylactic shock—Lovastatin—atherosclerosis	0.000195	0.0014	CcSEcCtD
Valproic Acid—Muscle spasms—Pravastatin—atherosclerosis	0.000194	0.0014	CcSEcCtD
Valproic Acid—Infection—Lovastatin—atherosclerosis	0.000193	0.00139	CcSEcCtD
Valproic Acid—Vision blurred—Niacin—atherosclerosis	0.000193	0.00139	CcSEcCtD
Valproic Acid—Confusional state—Ezetimibe—atherosclerosis	0.000193	0.00139	CcSEcCtD
Valproic Acid—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000191	0.00138	CcSEcCtD
Valproic Acid—Thrombocytopenia—Lovastatin—atherosclerosis	0.000191	0.00137	CcSEcCtD
Valproic Acid—Vision blurred—Pravastatin—atherosclerosis	0.00019	0.00137	CcSEcCtD
Valproic Acid—Chest pain—Simvastatin—atherosclerosis	0.00019	0.00137	CcSEcCtD
Valproic Acid—Arthralgia—Simvastatin—atherosclerosis	0.00019	0.00137	CcSEcCtD
Valproic Acid—Myalgia—Simvastatin—atherosclerosis	0.00019	0.00137	CcSEcCtD
Valproic Acid—Infection—Ezetimibe—atherosclerosis	0.00019	0.00137	CcSEcCtD
Valproic Acid—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000189	0.00136	CcSEcCtD
Valproic Acid—Anxiety—Simvastatin—atherosclerosis	0.000189	0.00136	CcSEcCtD
Valproic Acid—Tremor—Pravastatin—atherosclerosis	0.000189	0.00136	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000188	0.00135	CcSEcCtD
Valproic Acid—Discomfort—Simvastatin—atherosclerosis	0.000188	0.00135	CcSEcCtD
Valproic Acid—Nervous system disorder—Ezetimibe—atherosclerosis	0.000187	0.00135	CcSEcCtD
Valproic Acid—Angioedema—Niacin—atherosclerosis	0.000187	0.00135	CcSEcCtD
Valproic Acid—Ill-defined disorder—Pravastatin—atherosclerosis	0.000187	0.00135	CcSEcCtD
Valproic Acid—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000187	0.00135	CcSEcCtD
Valproic Acid—Anaemia—Pravastatin—atherosclerosis	0.000186	0.00134	CcSEcCtD
Valproic Acid—Anorexia—Lovastatin—atherosclerosis	0.000186	0.00134	CcSEcCtD
Valproic Acid—Skin disorder—Ezetimibe—atherosclerosis	0.000185	0.00134	CcSEcCtD
Valproic Acid—Angioedema—Pravastatin—atherosclerosis	0.000184	0.00133	CcSEcCtD
Valproic Acid—Vertigo—Niacin—atherosclerosis	0.000184	0.00133	CcSEcCtD
Valproic Acid—Confusional state—Simvastatin—atherosclerosis	0.000184	0.00132	CcSEcCtD
Valproic Acid—Leukopenia—Niacin—atherosclerosis	0.000183	0.00132	CcSEcCtD
Valproic Acid—PTGS1—adipose tissue—atherosclerosis	0.000183	0.00734	CbGeAlD
Valproic Acid—Urticaria—Rosuvastatin—atherosclerosis	0.000183	0.00132	CcSEcCtD
Valproic Acid—Oedema—Simvastatin—atherosclerosis	0.000182	0.00131	CcSEcCtD
Valproic Acid—Anaphylactic shock—Simvastatin—atherosclerosis	0.000182	0.00131	CcSEcCtD
Valproic Acid—Malaise—Pravastatin—atherosclerosis	0.000182	0.00131	CcSEcCtD
Valproic Acid—Abdominal pain—Rosuvastatin—atherosclerosis	0.000182	0.00131	CcSEcCtD
Valproic Acid—CYP2C19—liver—atherosclerosis	0.000182	0.00727	CbGeAlD
Valproic Acid—Vertigo—Pravastatin—atherosclerosis	0.000181	0.00131	CcSEcCtD
Valproic Acid—Palpitations—Niacin—atherosclerosis	0.000181	0.00131	CcSEcCtD
Valproic Acid—Infection—Simvastatin—atherosclerosis	0.000181	0.0013	CcSEcCtD
Valproic Acid—Leukopenia—Pravastatin—atherosclerosis	0.000181	0.0013	CcSEcCtD
Valproic Acid—Cough—Niacin—atherosclerosis	0.000179	0.00129	CcSEcCtD
Valproic Acid—Thrombocytopenia—Simvastatin—atherosclerosis	0.000178	0.00129	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000177	0.00128	CcSEcCtD
Valproic Acid—Insomnia—Lovastatin—atherosclerosis	0.000176	0.00127	CcSEcCtD
Valproic Acid—Cough—Pravastatin—atherosclerosis	0.000176	0.00127	CcSEcCtD
Valproic Acid—Paraesthesia—Lovastatin—atherosclerosis	0.000175	0.00126	CcSEcCtD
Valproic Acid—Arthralgia—Niacin—atherosclerosis	0.000174	0.00126	CcSEcCtD
Valproic Acid—Myalgia—Niacin—atherosclerosis	0.000174	0.00126	CcSEcCtD
Valproic Acid—Hypertension—Pravastatin—atherosclerosis	0.000174	0.00126	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000174	0.00125	CcSEcCtD
Valproic Acid—Anorexia—Simvastatin—atherosclerosis	0.000174	0.00125	CcSEcCtD
Valproic Acid—Dyspnoea—Lovastatin—atherosclerosis	0.000174	0.00125	CcSEcCtD
Valproic Acid—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000173	0.00125	CcSEcCtD
Valproic Acid—Insomnia—Ezetimibe—atherosclerosis	0.000173	0.00124	CcSEcCtD
Valproic Acid—Chest pain—Pravastatin—atherosclerosis	0.000172	0.00124	CcSEcCtD
Valproic Acid—Arthralgia—Pravastatin—atherosclerosis	0.000172	0.00124	CcSEcCtD
Valproic Acid—Myalgia—Pravastatin—atherosclerosis	0.000172	0.00124	CcSEcCtD
Valproic Acid—Paraesthesia—Ezetimibe—atherosclerosis	0.000171	0.00124	CcSEcCtD
Valproic Acid—Dyspepsia—Lovastatin—atherosclerosis	0.000171	0.00124	CcSEcCtD
Valproic Acid—Anxiety—Pravastatin—atherosclerosis	0.000171	0.00123	CcSEcCtD
Valproic Acid—Dry mouth—Niacin—atherosclerosis	0.000171	0.00123	CcSEcCtD
Valproic Acid—Dyspnoea—Ezetimibe—atherosclerosis	0.00017	0.00123	CcSEcCtD
Valproic Acid—Discomfort—Pravastatin—atherosclerosis	0.00017	0.00122	CcSEcCtD
Valproic Acid—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000169	0.00122	CcSEcCtD
Valproic Acid—Decreased appetite—Lovastatin—atherosclerosis	0.000169	0.00122	CcSEcCtD
Valproic Acid—Dyspepsia—Ezetimibe—atherosclerosis	0.000168	0.00121	CcSEcCtD
Valproic Acid—Fatigue—Lovastatin—atherosclerosis	0.000168	0.00121	CcSEcCtD
Valproic Acid—Anaphylactic shock—Niacin—atherosclerosis	0.000167	0.00121	CcSEcCtD
Valproic Acid—Oedema—Niacin—atherosclerosis	0.000167	0.00121	CcSEcCtD
Valproic Acid—Pain—Lovastatin—atherosclerosis	0.000166	0.0012	CcSEcCtD
Valproic Acid—Constipation—Lovastatin—atherosclerosis	0.000166	0.0012	CcSEcCtD
Valproic Acid—Confusional state—Pravastatin—atherosclerosis	0.000166	0.0012	CcSEcCtD
Valproic Acid—Decreased appetite—Ezetimibe—atherosclerosis	0.000166	0.0012	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000166	0.0012	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000165	0.00119	CcSEcCtD
Valproic Acid—Asthenia—Rosuvastatin—atherosclerosis	0.000165	0.00119	CcSEcCtD
Valproic Acid—Insomnia—Simvastatin—atherosclerosis	0.000165	0.00119	CcSEcCtD
Valproic Acid—Oedema—Pravastatin—atherosclerosis	0.000165	0.00119	CcSEcCtD
Valproic Acid—Anaphylactic shock—Pravastatin—atherosclerosis	0.000165	0.00119	CcSEcCtD
Valproic Acid—Fatigue—Ezetimibe—atherosclerosis	0.000165	0.00119	CcSEcCtD
Valproic Acid—SLC22A5—liver—atherosclerosis	0.000164	0.00656	CbGeAlD
Valproic Acid—Infection—Pravastatin—atherosclerosis	0.000164	0.00118	CcSEcCtD
Valproic Acid—Paraesthesia—Simvastatin—atherosclerosis	0.000164	0.00118	CcSEcCtD
Valproic Acid—Pain—Ezetimibe—atherosclerosis	0.000163	0.00118	CcSEcCtD
Valproic Acid—Constipation—Ezetimibe—atherosclerosis	0.000163	0.00118	CcSEcCtD
Valproic Acid—Tachycardia—Niacin—atherosclerosis	0.000163	0.00118	CcSEcCtD
Valproic Acid—Pruritus—Rosuvastatin—atherosclerosis	0.000163	0.00117	CcSEcCtD
Valproic Acid—Skin disorder—Niacin—atherosclerosis	0.000162	0.00117	CcSEcCtD
Valproic Acid—Dyspnoea—Simvastatin—atherosclerosis	0.000162	0.00117	CcSEcCtD
Valproic Acid—Hyperhidrosis—Niacin—atherosclerosis	0.000162	0.00117	CcSEcCtD
Valproic Acid—Thrombocytopenia—Pravastatin—atherosclerosis	0.000161	0.00116	CcSEcCtD
Valproic Acid—Feeling abnormal—Lovastatin—atherosclerosis	0.00016	0.00116	CcSEcCtD
Valproic Acid—Dyspepsia—Simvastatin—atherosclerosis	0.00016	0.00116	CcSEcCtD
Valproic Acid—Anorexia—Niacin—atherosclerosis	0.000159	0.00115	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000159	0.00115	CcSEcCtD
Valproic Acid—Hyperhidrosis—Pravastatin—atherosclerosis	0.000159	0.00115	CcSEcCtD
Valproic Acid—CYP2C8—liver—atherosclerosis	0.000158	0.00635	CbGeAlD
Valproic Acid—Decreased appetite—Simvastatin—atherosclerosis	0.000158	0.00114	CcSEcCtD
Valproic Acid—Feeling abnormal—Ezetimibe—atherosclerosis	0.000157	0.00113	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000157	0.00113	CcSEcCtD
Valproic Acid—Diarrhoea—Rosuvastatin—atherosclerosis	0.000157	0.00113	CcSEcCtD
Valproic Acid—Fatigue—Simvastatin—atherosclerosis	0.000157	0.00113	CcSEcCtD
Valproic Acid—Anorexia—Pravastatin—atherosclerosis	0.000157	0.00113	CcSEcCtD
Valproic Acid—Hypotension—Niacin—atherosclerosis	0.000156	0.00113	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000156	0.00113	CcSEcCtD
Valproic Acid—Pain—Simvastatin—atherosclerosis	0.000156	0.00112	CcSEcCtD
Valproic Acid—Constipation—Simvastatin—atherosclerosis	0.000156	0.00112	CcSEcCtD
Valproic Acid—Urticaria—Lovastatin—atherosclerosis	0.000155	0.00111	CcSEcCtD
Valproic Acid—Abdominal pain—Lovastatin—atherosclerosis	0.000154	0.00111	CcSEcCtD
Valproic Acid—Body temperature increased—Lovastatin—atherosclerosis	0.000154	0.00111	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000152	0.0011	CcSEcCtD
Valproic Acid—Dizziness—Rosuvastatin—atherosclerosis	0.000152	0.0011	CcSEcCtD
Valproic Acid—Urticaria—Ezetimibe—atherosclerosis	0.000152	0.00109	CcSEcCtD
Valproic Acid—Insomnia—Niacin—atherosclerosis	0.000151	0.00109	CcSEcCtD
Valproic Acid—Abdominal pain—Ezetimibe—atherosclerosis	0.000151	0.00109	CcSEcCtD
Valproic Acid—Body temperature increased—Ezetimibe—atherosclerosis	0.000151	0.00109	CcSEcCtD
Valproic Acid—Paraesthesia—Niacin—atherosclerosis	0.00015	0.00108	CcSEcCtD
Valproic Acid—Feeling abnormal—Simvastatin—atherosclerosis	0.00015	0.00108	CcSEcCtD
Valproic Acid—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00015	0.00108	CcSEcCtD
Valproic Acid—Dyspnoea—Niacin—atherosclerosis	0.000149	0.00107	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000149	0.00107	CcSEcCtD
Valproic Acid—Insomnia—Pravastatin—atherosclerosis	0.000149	0.00107	CcSEcCtD
Valproic Acid—Somnolence—Niacin—atherosclerosis	0.000149	0.00107	CcSEcCtD
Valproic Acid—CYP1A2—liver—atherosclerosis	0.000148	0.00594	CbGeAlD
Valproic Acid—Paraesthesia—Pravastatin—atherosclerosis	0.000148	0.00107	CcSEcCtD
Valproic Acid—Dyspepsia—Niacin—atherosclerosis	0.000147	0.00106	CcSEcCtD
Valproic Acid—Dyspnoea—Pravastatin—atherosclerosis	0.000147	0.00106	CcSEcCtD
Valproic Acid—Decreased appetite—Niacin—atherosclerosis	0.000145	0.00105	CcSEcCtD
Valproic Acid—Dyspepsia—Pravastatin—atherosclerosis	0.000145	0.00104	CcSEcCtD
Valproic Acid—Rash—Rosuvastatin—atherosclerosis	0.000145	0.00104	CcSEcCtD
Valproic Acid—Dermatitis—Rosuvastatin—atherosclerosis	0.000145	0.00104	CcSEcCtD
Valproic Acid—Urticaria—Simvastatin—atherosclerosis	0.000145	0.00104	CcSEcCtD
Valproic Acid—Gastrointestinal disorder—Niacin—atherosclerosis	0.000144	0.00104	CcSEcCtD
Valproic Acid—Abdominal pain—Simvastatin—atherosclerosis	0.000144	0.00104	CcSEcCtD
Valproic Acid—Body temperature increased—Simvastatin—atherosclerosis	0.000144	0.00104	CcSEcCtD
Valproic Acid—Headache—Rosuvastatin—atherosclerosis	0.000144	0.00104	CcSEcCtD
Valproic Acid—Hypersensitivity—Lovastatin—atherosclerosis	0.000143	0.00103	CcSEcCtD
Valproic Acid—Decreased appetite—Pravastatin—atherosclerosis	0.000143	0.00103	CcSEcCtD
Valproic Acid—CYP3A5—liver—atherosclerosis	0.000143	0.00573	CbGeAlD
Valproic Acid—Pain—Niacin—atherosclerosis	0.000143	0.00103	CcSEcCtD
Valproic Acid—CYP2B6—liver—atherosclerosis	0.000142	0.0057	CbGeAlD
Valproic Acid—Fatigue—Pravastatin—atherosclerosis	0.000142	0.00102	CcSEcCtD
Valproic Acid—Pain—Pravastatin—atherosclerosis	0.000141	0.00101	CcSEcCtD
Valproic Acid—Constipation—Pravastatin—atherosclerosis	0.000141	0.00101	CcSEcCtD
Valproic Acid—CYP2C9—liver—atherosclerosis	0.000141	0.00564	CbGeAlD
Valproic Acid—Hypersensitivity—Ezetimibe—atherosclerosis	0.000141	0.00101	CcSEcCtD
Valproic Acid—Asthenia—Lovastatin—atherosclerosis	0.00014	0.00101	CcSEcCtD
Valproic Acid—Pruritus—Lovastatin—atherosclerosis	0.000138	0.000993	CcSEcCtD
Valproic Acid—Asthenia—Ezetimibe—atherosclerosis	0.000137	0.000988	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Niacin—atherosclerosis	0.000137	0.000986	CcSEcCtD
Valproic Acid—Nausea—Rosuvastatin—atherosclerosis	0.000136	0.000984	CcSEcCtD
Valproic Acid—Feeling abnormal—Pravastatin—atherosclerosis	0.000136	0.000978	CcSEcCtD
Valproic Acid—Pruritus—Ezetimibe—atherosclerosis	0.000135	0.000974	CcSEcCtD
Valproic Acid—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000135	0.00097	CcSEcCtD
Valproic Acid—Hypersensitivity—Simvastatin—atherosclerosis	0.000134	0.000967	CcSEcCtD
Valproic Acid—Diarrhoea—Lovastatin—atherosclerosis	0.000133	0.00096	CcSEcCtD
Valproic Acid—Urticaria—Niacin—atherosclerosis	0.000133	0.000958	CcSEcCtD
Valproic Acid—Body temperature increased—Niacin—atherosclerosis	0.000132	0.000953	CcSEcCtD
Valproic Acid—Abdominal pain—Niacin—atherosclerosis	0.000132	0.000953	CcSEcCtD
Valproic Acid—Urticaria—Pravastatin—atherosclerosis	0.000131	0.000943	CcSEcCtD
Valproic Acid—Asthenia—Simvastatin—atherosclerosis	0.000131	0.000942	CcSEcCtD
Valproic Acid—Diarrhoea—Ezetimibe—atherosclerosis	0.000131	0.000942	CcSEcCtD
Valproic Acid—Abdominal pain—Pravastatin—atherosclerosis	0.00013	0.000938	CcSEcCtD
Valproic Acid—Body temperature increased—Pravastatin—atherosclerosis	0.00013	0.000938	CcSEcCtD
Valproic Acid—Pruritus—Simvastatin—atherosclerosis	0.000129	0.000929	CcSEcCtD
Valproic Acid—Dizziness—Lovastatin—atherosclerosis	0.000129	0.000928	CcSEcCtD
Valproic Acid—Dizziness—Ezetimibe—atherosclerosis	0.000126	0.00091	CcSEcCtD
Valproic Acid—Diarrhoea—Simvastatin—atherosclerosis	0.000125	0.000898	CcSEcCtD
Valproic Acid—Vomiting—Lovastatin—atherosclerosis	0.000124	0.000892	CcSEcCtD
Valproic Acid—Hypersensitivity—Niacin—atherosclerosis	0.000123	0.000888	CcSEcCtD
Valproic Acid—Rash—Lovastatin—atherosclerosis	0.000123	0.000885	CcSEcCtD
Valproic Acid—Dermatitis—Lovastatin—atherosclerosis	0.000123	0.000884	CcSEcCtD
Valproic Acid—Headache—Lovastatin—atherosclerosis	0.000122	0.000879	CcSEcCtD
Valproic Acid—Vomiting—Ezetimibe—atherosclerosis	0.000121	0.000875	CcSEcCtD
Valproic Acid—Hypersensitivity—Pravastatin—atherosclerosis	0.000121	0.000874	CcSEcCtD
Valproic Acid—Dizziness—Simvastatin—atherosclerosis	0.00012	0.000868	CcSEcCtD
Valproic Acid—Rash—Ezetimibe—atherosclerosis	0.00012	0.000868	CcSEcCtD
Valproic Acid—Dermatitis—Ezetimibe—atherosclerosis	0.00012	0.000867	CcSEcCtD
Valproic Acid—Asthenia—Niacin—atherosclerosis	0.00012	0.000865	CcSEcCtD
Valproic Acid—Headache—Ezetimibe—atherosclerosis	0.00012	0.000862	CcSEcCtD
Valproic Acid—Pruritus—Niacin—atherosclerosis	0.000118	0.000853	CcSEcCtD
Valproic Acid—Asthenia—Pravastatin—atherosclerosis	0.000118	0.000851	CcSEcCtD
Valproic Acid—Pruritus—Pravastatin—atherosclerosis	0.000116	0.00084	CcSEcCtD
Valproic Acid—Vomiting—Simvastatin—atherosclerosis	0.000116	0.000835	CcSEcCtD
Valproic Acid—Nausea—Lovastatin—atherosclerosis	0.000116	0.000834	CcSEcCtD
Valproic Acid—Rash—Simvastatin—atherosclerosis	0.000115	0.000828	CcSEcCtD
Valproic Acid—Dermatitis—Simvastatin—atherosclerosis	0.000115	0.000827	CcSEcCtD
Valproic Acid—Diarrhoea—Niacin—atherosclerosis	0.000114	0.000825	CcSEcCtD
Valproic Acid—Headache—Simvastatin—atherosclerosis	0.000114	0.000822	CcSEcCtD
Valproic Acid—Nausea—Ezetimibe—atherosclerosis	0.000113	0.000818	CcSEcCtD
Valproic Acid—Diarrhoea—Pravastatin—atherosclerosis	0.000113	0.000812	CcSEcCtD
Valproic Acid—Dizziness—Niacin—atherosclerosis	0.000111	0.000797	CcSEcCtD
Valproic Acid—Dizziness—Pravastatin—atherosclerosis	0.000109	0.000785	CcSEcCtD
Valproic Acid—Nausea—Simvastatin—atherosclerosis	0.000108	0.00078	CcSEcCtD
Valproic Acid—CYP3A4—liver—atherosclerosis	0.000107	0.0043	CbGeAlD
Valproic Acid—Vomiting—Niacin—atherosclerosis	0.000106	0.000766	CcSEcCtD
Valproic Acid—Rash—Niacin—atherosclerosis	0.000105	0.00076	CcSEcCtD
Valproic Acid—Dermatitis—Niacin—atherosclerosis	0.000105	0.000759	CcSEcCtD
Valproic Acid—Headache—Niacin—atherosclerosis	0.000105	0.000755	CcSEcCtD
Valproic Acid—Vomiting—Pravastatin—atherosclerosis	0.000105	0.000755	CcSEcCtD
Valproic Acid—Rash—Pravastatin—atherosclerosis	0.000104	0.000748	CcSEcCtD
Valproic Acid—Dermatitis—Pravastatin—atherosclerosis	0.000104	0.000748	CcSEcCtD
Valproic Acid—Headache—Pravastatin—atherosclerosis	0.000103	0.000743	CcSEcCtD
Valproic Acid—Nausea—Niacin—atherosclerosis	9.93e-05	0.000716	CcSEcCtD
Valproic Acid—Nausea—Pravastatin—atherosclerosis	9.78e-05	0.000705	CcSEcCtD
Valproic Acid—CYP1A2—Metabolism—BGN—atherosclerosis	4.57e-06	4.88e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PPARG—atherosclerosis	4.56e-06	4.87e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.54e-06	4.86e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—PTGS2—atherosclerosis	4.53e-06	4.85e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	4.53e-06	4.85e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—MAPK3—atherosclerosis	4.53e-06	4.84e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOA5—atherosclerosis	4.52e-06	4.83e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LCAT—atherosclerosis	4.51e-06	4.83e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—FABP4—atherosclerosis	4.51e-06	4.83e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPARA—atherosclerosis	4.49e-06	4.81e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—INS—atherosclerosis	4.47e-06	4.78e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—SCARB1—atherosclerosis	4.44e-06	4.75e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOA4—atherosclerosis	4.43e-06	4.74e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—PTGS2—atherosclerosis	4.41e-06	4.72e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NAMPT—atherosclerosis	4.41e-06	4.72e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—TGFB1—atherosclerosis	4.39e-06	4.7e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	4.39e-06	4.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.39e-06	4.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—LIPC—atherosclerosis	4.38e-06	4.69e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOC3—atherosclerosis	4.36e-06	4.66e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP7A1—atherosclerosis	4.35e-06	4.65e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AGT—atherosclerosis	4.35e-06	4.65e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	4.35e-06	4.65e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—MTHFR—atherosclerosis	4.33e-06	4.63e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—LDLR—atherosclerosis	4.33e-06	4.63e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.32e-06	4.62e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	4.3e-06	4.6e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—APOE—atherosclerosis	4.26e-06	4.56e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	4.26e-06	4.56e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.25e-06	4.55e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPARA—atherosclerosis	4.25e-06	4.54e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—HMOX1—atherosclerosis	4.24e-06	4.54e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.24e-06	4.53e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CETP—atherosclerosis	4.23e-06	4.52e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—CAV1—atherosclerosis	4.23e-06	4.52e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—APOA1—atherosclerosis	4.22e-06	4.51e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALOX5—atherosclerosis	4.2e-06	4.49e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HMGCR—atherosclerosis	4.19e-06	4.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ABCA1—atherosclerosis	4.19e-06	4.48e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—HMOX1—atherosclerosis	4.15e-06	4.44e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—CXCL8—atherosclerosis	4.13e-06	4.41e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AGT—atherosclerosis	4.12e-06	4.4e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—ALB—atherosclerosis	4.1e-06	4.38e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—APOB—atherosclerosis	4.07e-06	4.35e-05	CbGpPWpGaD
Valproic Acid—UGT1A6—Metabolism—AKT1—atherosclerosis	4.06e-06	4.34e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—SCARB1—atherosclerosis	4.05e-06	4.33e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—APOE—atherosclerosis	4.03e-06	4.31e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CYP27A1—atherosclerosis	4.02e-06	4.3e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—CAV1—atherosclerosis	4e-06	4.27e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—APOA1—atherosclerosis	3.99e-06	4.26e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—APOB—atherosclerosis	3.97e-06	4.25e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GSTM1—atherosclerosis	3.95e-06	4.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.94e-06	4.22e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—NOS3—atherosclerosis	3.92e-06	4.19e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.88e-06	4.15e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—LPL—atherosclerosis	3.88e-06	4.15e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GSTM1—atherosclerosis	3.87e-06	4.13e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PIK3CG—atherosclerosis	3.85e-06	4.12e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HMGCR—atherosclerosis	3.82e-06	4.09e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOA2—atherosclerosis	3.81e-06	4.08e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.81e-06	4.08e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.81e-06	4.08e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.81e-06	4.08e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—LPL—atherosclerosis	3.79e-06	4.06e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—GPX1—atherosclerosis	3.79e-06	4.05e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.78e-06	4.05e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NAMPT—atherosclerosis	3.77e-06	4.03e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.77e-06	4.03e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.75e-06	4.01e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—LIPC—atherosclerosis	3.75e-06	4.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ABCA1—atherosclerosis	3.74e-06	4e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MMP9—atherosclerosis	3.73e-06	3.99e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOC3—atherosclerosis	3.72e-06	3.98e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PPARG—atherosclerosis	3.71e-06	3.97e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—GPX1—atherosclerosis	3.7e-06	3.96e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—LDLR—atherosclerosis	3.7e-06	3.96e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—NFKB1—atherosclerosis	3.69e-06	3.95e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CD36—atherosclerosis	3.69e-06	3.94e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—INS—atherosclerosis	3.64e-06	3.9e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PIK3CG—atherosclerosis	3.64e-06	3.89e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LPA—atherosclerosis	3.64e-06	3.89e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK8—atherosclerosis	3.63e-06	3.88e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CETP—atherosclerosis	3.61e-06	3.86e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CD36—atherosclerosis	3.61e-06	3.86e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—HMOX1—atherosclerosis	3.59e-06	3.84e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—PTGS2—atherosclerosis	3.58e-06	3.83e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—BGN—atherosclerosis	3.52e-06	3.77e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PPARG—atherosclerosis	3.51e-06	3.76e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—MTHFR—atherosclerosis	3.5e-06	3.74e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOA5—atherosclerosis	3.49e-06	3.73e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—SCARB1—atherosclerosis	3.46e-06	3.7e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.45e-06	3.69e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—INS—atherosclerosis	3.45e-06	3.68e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—APOB—atherosclerosis	3.44e-06	3.68e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARA—atherosclerosis	3.43e-06	3.67e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—MTHFR—atherosclerosis	3.42e-06	3.65e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ABCA1—atherosclerosis	3.41e-06	3.64e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.37e-06	3.6e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.36e-06	3.59e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARA—atherosclerosis	3.35e-06	3.58e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—VEGFA—atherosclerosis	3.35e-06	3.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GSTM1—atherosclerosis	3.35e-06	3.58e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—ALB—atherosclerosis	3.34e-06	3.57e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AGT—atherosclerosis	3.32e-06	3.55e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—STAT3—atherosclerosis	3.32e-06	3.55e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—IL6—atherosclerosis	3.31e-06	3.54e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Gene Expression—AKT1—atherosclerosis	3.29e-06	3.52e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—LPL—atherosclerosis	3.29e-06	3.51e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HMGCR—atherosclerosis	3.27e-06	3.49e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—APOE—atherosclerosis	3.25e-06	3.48e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AGT—atherosclerosis	3.25e-06	3.47e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.24e-06	3.47e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—CAV1—atherosclerosis	3.22e-06	3.45e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—APOA1—atherosclerosis	3.22e-06	3.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—HMOX1—atherosclerosis	3.21e-06	3.43e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—GPX1—atherosclerosis	3.21e-06	3.43e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—NOS3—atherosclerosis	3.2e-06	3.42e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—APOE—atherosclerosis	3.18e-06	3.4e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—MAPK3—atherosclerosis	3.17e-06	3.39e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—ALB—atherosclerosis	3.16e-06	3.38e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—CAV1—atherosclerosis	3.15e-06	3.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—APOA1—atherosclerosis	3.14e-06	3.36e-05	CbGpPWpGaD
Valproic Acid—UGT1A4—Metabolism—AKT1—atherosclerosis	3.14e-06	3.35e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CD36—atherosclerosis	3.12e-06	3.34e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—TGFB1—atherosclerosis	3.08e-06	3.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APOB—atherosclerosis	3.07e-06	3.29e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Disease—AKT1—atherosclerosis	3.05e-06	3.27e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—NOS3—atherosclerosis	3.02e-06	3.23e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GSTM1—atherosclerosis	2.99e-06	3.2e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—MTHFR—atherosclerosis	2.96e-06	3.16e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.95e-06	3.15e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PIK3CG—atherosclerosis	2.94e-06	3.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—LPL—atherosclerosis	2.93e-06	3.14e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—HMOX1—atherosclerosis	2.92e-06	3.13e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—PTGS2—atherosclerosis	2.92e-06	3.12e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ABCA1—atherosclerosis	2.91e-06	3.11e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.91e-06	3.11e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARA—atherosclerosis	2.9e-06	3.1e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LIPC—atherosclerosis	2.89e-06	3.09e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOC3—atherosclerosis	2.87e-06	3.07e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PIK3CG—atherosclerosis	2.87e-06	3.07e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—GPX1—atherosclerosis	2.86e-06	3.06e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LDLR—atherosclerosis	2.86e-06	3.05e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PPARG—atherosclerosis	2.83e-06	3.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AGT—atherosclerosis	2.81e-06	3.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOB—atherosclerosis	2.8e-06	3e-05	CbGpPWpGaD
Valproic Acid—SLC16A1—Metabolism—AKT1—atherosclerosis	2.8e-06	2.99e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CETP—atherosclerosis	2.79e-06	2.98e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CD36—atherosclerosis	2.79e-06	2.98e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—INS—atherosclerosis	2.78e-06	2.97e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PPARG—atherosclerosis	2.77e-06	2.96e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—PTGS2—atherosclerosis	2.76e-06	2.95e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—APOE—atherosclerosis	2.75e-06	2.95e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—CAV1—atherosclerosis	2.73e-06	2.92e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GSTM1—atherosclerosis	2.73e-06	2.91e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—APOA1—atherosclerosis	2.72e-06	2.91e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—INS—atherosclerosis	2.72e-06	2.91e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—LPL—atherosclerosis	2.67e-06	2.86e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.67e-06	2.86e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—MTHFR—atherosclerosis	2.64e-06	2.82e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—GPX1—atherosclerosis	2.61e-06	2.79e-05	CbGpPWpGaD
Valproic Acid—UGT1A3—Metabolism—AKT1—atherosclerosis	2.61e-06	2.79e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARA—atherosclerosis	2.59e-06	2.77e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—ALB—atherosclerosis	2.55e-06	2.73e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CD36—atherosclerosis	2.54e-06	2.72e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.52e-06	2.7e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AGT—atherosclerosis	2.51e-06	2.68e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—HMOX1—atherosclerosis	2.5e-06	2.67e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—ALB—atherosclerosis	2.49e-06	2.66e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.49e-06	2.66e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APOE—atherosclerosis	2.46e-06	2.63e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—NOS3—atherosclerosis	2.44e-06	2.61e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—CAV1—atherosclerosis	2.44e-06	2.61e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—APOA1—atherosclerosis	2.43e-06	2.6e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.41e-06	2.58e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PPARG—atherosclerosis	2.4e-06	2.57e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOB—atherosclerosis	2.39e-06	2.56e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—NOS3—atherosclerosis	2.38e-06	2.55e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARA—atherosclerosis	2.36e-06	2.53e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—INS—atherosclerosis	2.35e-06	2.52e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GSTM1—atherosclerosis	2.33e-06	2.49e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—IL6—atherosclerosis	2.32e-06	2.48e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AGT—atherosclerosis	2.29e-06	2.45e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—LPL—atherosclerosis	2.29e-06	2.44e-05	CbGpPWpGaD
Valproic Acid—CYP2C18—Metabolism—AKT1—atherosclerosis	2.28e-06	2.44e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.25e-06	2.4e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOE—atherosclerosis	2.24e-06	2.4e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—GPX1—atherosclerosis	2.23e-06	2.38e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—PTGS2—atherosclerosis	2.23e-06	2.38e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—CAV1—atherosclerosis	2.22e-06	2.38e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PIK3CG—atherosclerosis	2.22e-06	2.37e-05	CbGpPWpGaD
Valproic Acid—UGT2B7—Metabolism—AKT1—atherosclerosis	2.22e-06	2.37e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—APOA1—atherosclerosis	2.22e-06	2.37e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—PTGS2—atherosclerosis	2.18e-06	2.33e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CD36—atherosclerosis	2.17e-06	2.32e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—ALB—atherosclerosis	2.16e-06	2.31e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PPARG—atherosclerosis	2.14e-06	2.29e-05	CbGpPWpGaD
Valproic Acid—HDAC2—Signaling Pathways—AKT1—atherosclerosis	2.14e-06	2.29e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—INS—atherosclerosis	2.1e-06	2.25e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—NOS3—atherosclerosis	2.06e-06	2.21e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—MTHFR—atherosclerosis	2.06e-06	2.2e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.02e-06	2.16e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARA—atherosclerosis	2.02e-06	2.16e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AGT—atherosclerosis	1.96e-06	2.09e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PPARG—atherosclerosis	1.95e-06	2.09e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.93e-06	2.06e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—ALB—atherosclerosis	1.93e-06	2.06e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOE—atherosclerosis	1.92e-06	2.05e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—INS—atherosclerosis	1.92e-06	2.05e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—CAV1—atherosclerosis	1.9e-06	2.03e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—APOA1—atherosclerosis	1.89e-06	2.03e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.89e-06	2.02e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOB—atherosclerosis	1.85e-06	1.98e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—NOS3—atherosclerosis	1.84e-06	1.97e-05	CbGpPWpGaD
Valproic Acid—UGT1A9—Metabolism—AKT1—atherosclerosis	1.8e-06	1.93e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.8e-06	1.92e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—LPL—atherosclerosis	1.76e-06	1.89e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—ALB—atherosclerosis	1.76e-06	1.88e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PIK3CG—atherosclerosis	1.73e-06	1.85e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—GPX1—atherosclerosis	1.72e-06	1.84e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—PTGS2—atherosclerosis	1.68e-06	1.8e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—NOS3—atherosclerosis	1.68e-06	1.8e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CD36—atherosclerosis	1.68e-06	1.79e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PPARG—atherosclerosis	1.67e-06	1.78e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—INS—atherosclerosis	1.64e-06	1.75e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.59e-06	1.7e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARA—atherosclerosis	1.56e-06	1.67e-05	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.54e-06	1.64e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AGT—atherosclerosis	1.51e-06	1.61e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—ALB—atherosclerosis	1.5e-06	1.6e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOE—atherosclerosis	1.48e-06	1.58e-05	CbGpPWpGaD
Valproic Acid—PTGS1—Metabolism—AKT1—atherosclerosis	1.47e-06	1.57e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—CAV1—atherosclerosis	1.47e-06	1.57e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—APOA1—atherosclerosis	1.46e-06	1.56e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—NOS3—atherosclerosis	1.44e-06	1.53e-05	CbGpPWpGaD
Valproic Acid—CYP2A6—Metabolism—AKT1—atherosclerosis	1.39e-06	1.49e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.33e-06	1.43e-05	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—PTGS2—atherosclerosis	1.31e-06	1.4e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PPARG—atherosclerosis	1.29e-06	1.38e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—INS—atherosclerosis	1.26e-06	1.35e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—ALB—atherosclerosis	1.16e-06	1.24e-05	CbGpPWpGaD
Valproic Acid—CYP2B6—Metabolism—AKT1—atherosclerosis	1.12e-06	1.2e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—NOS3—atherosclerosis	1.11e-06	1.18e-05	CbGpPWpGaD
Valproic Acid—CYP3A5—Metabolism—AKT1—atherosclerosis	1.1e-06	1.17e-05	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.01e-06	1.08e-05	CbGpPWpGaD
Valproic Acid—CYP2C8—Metabolism—AKT1—atherosclerosis	9.49e-07	1.01e-05	CbGpPWpGaD
Valproic Acid—CYP2C19—Metabolism—AKT1—atherosclerosis	8.47e-07	9.05e-06	CbGpPWpGaD
Valproic Acid—CYP2C9—Metabolism—AKT1—atherosclerosis	7.72e-07	8.26e-06	CbGpPWpGaD
Valproic Acid—CYP1A2—Metabolism—AKT1—atherosclerosis	6.6e-07	7.06e-06	CbGpPWpGaD
Valproic Acid—CYP3A4—Metabolism—AKT1—atherosclerosis	5.09e-07	5.45e-06	CbGpPWpGaD
